Corrigendum to 'A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance' [Genes Dis 694 (2019) 419–430]

MLA

Wei Wang, et al. “Corrigendum to ‘A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance’ [Genes Dis 694 (2019) 419–430].” Genes and Diseases, vol. 7, no. 1, Mar. 2020, pp. 160–61. EBSCOhost, https://doi.org/10.1016/j.gendis.2019.12.006.

APA

Wei Wang, Bo Hu, Jiang-Jiang Qin, Jianwen Cheng, Xin Li, Mehrdad Rajaei, Jia Fan, Xin-Rong Yang, & Ruiwen Zhang. (2020). Corrigendum to “A novel inhibitor of MDM2 oncogene blocks metastasis of hepatocellular carcinoma and overcomes chemoresistance” [Genes Dis 694 (2019) 419–430]. Genes and Diseases, 7(1), 160–161. https://doi.org/10.1016/j.gendis.2019.12.006

Chicago

Wei Wang, Bo Hu, Jiang-Jiang Qin, Jianwen Cheng, Xin Li, Mehrdad Rajaei, Jia Fan, Xin-Rong Yang, and Ruiwen Zhang. 2020. “Corrigendum to ‘A Novel Inhibitor of MDM2 Oncogene Blocks Metastasis of Hepatocellular Carcinoma and Overcomes Chemoresistance’ [Genes Dis 694 (2019) 419–430].” Genes and Diseases 7 (1): 160–61. doi:10.1016/j.gendis.2019.12.006.